Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04673721 · ClinicalTrials.gov registry record · NA
PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
NCT04673721: Completed NA study, sponsored by Duke University.
NCT04673721 is a NA study that has completed, run by Duke University. The registered enrollment target is 140 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04673721, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
Study Summary
The objective of the study is to assess the effect of fortified eggs (compared to a non-egg supplemented diet) and intermittent fasting (IF) (compared to a usual care diet) on biomarker profile at 4 months. This will be a 140-participant, 2x2 factorial, randomized clinical trial comparing fortified eggs vs. a non-egg supplemented diet and IF vs. usual care diet through 4 months. Participants will be randomized 1:1:1:1 to the four treatment groups. Participants will have in-person follow-up visits at 1- and 4- months (inclusive of laboratory assessments) in addition to telephone calls at months 2 and 3. A subset of patients (\~24 in each egg randomized strata) will undergo microbiome assessment at baseline and at 4 months.
Interventions
- DIETARY_SUPPLEMENT Fortified eggs
- BEHAVIORAL Intermittent fasting
- DIETARY_SUPPLEMENT Non-egg supplemented
- BEHAVIORAL Usual care diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2021-01-06 |
| Est. Completion | 2022-12-13 |
| Phase | NA |
What the finished NCT04673721 record still lists
NCT04673721 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 4 interventions - of which Fortified eggs is the first listed.
NCT04673721 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04673721 about?
NCT04673721 is a clinical study titled "PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health". The objective of the study is to assess the effect of fortified eggs (compared to a non-egg supplemented diet) and intermittent fasting (IF) (compared to a usual care diet) on biomarker profile at 4 months. This will be a 140-participant, 2x2 factorial, randomized clinical trial comparing fortified ...
What is the current status of trial NCT04673721?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2021-01-06. Estimated completion is 2022-12-13.
What interventions are being tested in trial NCT04673721?
The interventions under investigation include: Fortified eggs (DIETARY_SUPPLEMENT), Intermittent fasting (BEHAVIORAL), Non-egg supplemented (DIETARY_SUPPLEMENT), Usual care diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT04673721?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04673721's enrollment target sits among peer trials
140 713th of 2000 higher than 1,281 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI